We are pleased to announce that ENYDRON was selected for the preparation of the Environmental Impact Assessment Study (EIA) and the studies required for installation and operation licensing procedure of the new plant of REGULON (www.reguloninc.com) in Koropi, Attica, Greece. This plant will be active in developing and producing anticancer biopharmaceuticals using the technological platform of liposomes encapsulation. Through this platform the encapsulation of drugs significantly reduces the side effects of classical chemotherapy and improves the life quality of cancer patients. At a time when the country is tormented by the economic crisis, this investment is expected to create about 60 new jobs for highly qualified scientific staff and attract capital investments to strengthen this promising research subject. The new plant is expected to acquire license in 2016 and be set up in 2017.